FDA Investigator Humberto Z Gomez

Humberto Z Gomez has conducted inspections on 111 sites in 8 countries as of 29 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
111
Last Inspection Date:
29 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100008462
Countries of Inspections:
United States of America, China, Mexico, Australia, Canada, India, Poland, Vietnam
FDA Investigators that have inspected at least one site in common with Humberto Z Gomez:
Alanna L Mussawwir Bias, Alex G Kalugin, Althea A Williams, Amanda E Lewin, PhD, Angel K Sandhu, Angela Shepas, Anna L Marroquin, Anna L Viveros Hernandez, Anthony E Keller, RPh, Ashar P Parikh, Capri R Woolridge, CDR Rochelle B Young, RPh, MSA, Charles A Snipes, PhD, Christine M Parmentier, Christopher J Lee, Courtney N Long, Cynthia J Tsui, Cynthia Jim, CSO, Cynthia L Evitt, Darlene B Almogela, Deborah K Richardson, Dena L Jacobs, Diane Cvan Leeuwen, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Dylan D Yao, MD, PhD, Edward D Harris, Edward D Vains, Eric W Anderson, Erica L Nicoll, Estefania Fernandez, Gene D Arcy, Greg K Keshishyan, Gulshan R Anand, Helen J Hamaoka, Himanshu Gupta, PhD, Ingrid A Zambrana, Ismael Garibay, James A Lane, James R Fleckenstein, Jane M Kreis, Janet B Abt, Jazmine M Welcher, Jeffrey W Shrifter, DPM, Joan T Briones, Joanne M Fukuda, Jocelyn E Massey, Jonathan M Mcbride, Jorge L Bertran, Joseph M Willems, Julian C Hanson, Juliane Kjung Lau, Kara A Scheibner, PhD, Karen J Bak, Karen M Willis, Kelvin Cheung, Lance Mde Souza, MBA, Laurissa S Flowers, LCDR Jennifer H Rhyu, Li Hongpaul Yeh, PhD, Ligia M Sanders, Linda Linh N Adams, Linh Tu, Lirissia Mccoy, Lisa H Nakagawa, Lori J Silverstein, Lucila B Nwatu, Lydia S Chan, Macropolk, Marcus F Yambot, Marie K Kinkade, Mark C Saale, Mark E Baldwin, Mark E Chan, Mark W Babbitt, Mary Ewilkerson Brinsko, Mary R Hole, Melkamu Getie Kebtie, PhD, Ni Aye Khin, MD, Peter E Baker, Rebecca T Davis, Robert S Sweeton, Ronald L Koller, Ruben C Ayala, PharmD, Sandra S Saniga, Sara Jdent Acosta, Sarah A Hassas, Scott N Lim, Sergio Chavez (NMI), Shelley H Beausoleil, Sherri N Rohlf, MD, Steven M Galvez, Stuart Kim, Stuart W Russell, Suzanne M Healy, Tawny L Colling, Thea C Grome, Thomas Cote, Thomas W Gordon, Timothy C Grome, Timothy P Lafave, Tomanik'e C Banks, Xiaohan Cai, PhD, Yangmin Ning

Humberto Z Gomez's Documents

Publish Date Document Type Title
June, 2019 FDA 483 UCLA Medical IRB 1 (OHRPP) - Form 483, 2019-06-26
August, 2021 EIR Mehrnaz Hojjati MD - EIR, 2021-08-26
October, 2021 FDA 483 Jose Luis Bautista, M.D. - Form 483, 2021-10-06
June, 2017 FDA 483 Samer Nakhle, M.D. - Form 483, 2017-06-30
August, 2021 FDA 483 Mehrnaz Hojjati MD - Form 483, 2021-08-26
July, 2020 EIR Andrew D. Leavitt MD - EIR, 2020-07-02
February, 2023 FDA 483 Dante Pieramici, M.D. - Form 483, 2023-02-10
November, 2019 FDA 483 Hipolito Mariano, Jr., M.D. - Form 483, 2019-11-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more